PharMEDium Services, a national provider of pharmacy sterile intravenous admixture compounding services, has announced it is now offering propofol.
The company said that the drug, listed on the FDA's Current Drug Shortages list, is available in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system, according to a company news release.
Read the PharMEDium news release about the availability of propofol.
Read more about propofol:
- BCBS of North Carolina Holds Strong on Use of Deep Sedation for Endoscopic Procedures Policy
- ASA Supports DEA Proposal to List Propofol on Schedule IV
- Impact of the Propofol Shortage on Anesthesiologists: Q&A With ASA President Alexander Hannenberg